ID   TUBO-P2J
AC   CVCL_2A34
DR   Wikidata; Q54973346
RX   Patent=KR101309902B1;
RX   PubMed=25179116;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00272.
CC   Characteristics: Metastatic phenotype. Established from metastatic lung nodules in mice implanted with the parent cell line (PubMed=25179116).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB-neuT.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2A33 ! TUBO [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 6
//
RX   Patent=KR101309902B1;
RA   Park S.-K., Seo S.-K., Bae S.K., Choi J.-H., Jung H., Park J.-H.,
RA   Kim T.O., Park S.-G.;
RT   "Metastatic breast cancer cell line TUBO-P2J.";
RL   Patent number KR101309902B1, 17-Sep-2013.
//
RX   PubMed=25179116; DOI=10.1186/1471-2407-14-647;
RA   Song H., Kim T.O., Ma S.Y., Park J.-H., Choi J.-H., Kim J.-H.,
RA   Kang M.S., Bae S.K., Kim K.H., Kim T.H., Seo S.-K., Choi I.W.,
RA   Song G.A., Mortenson E.D., Fu Y.-X., Park S.;
RT   "Intratumoral heterogeneity impacts the response to anti-neu antibody
RT   therapy.";
RL   BMC Cancer 14:647.1-647.12(2014).
//